Merck Licenses Bone Drug for Generic Sale
50296
Merck & Company said it had signed a deal for an authorized generic form of its blockbuster osteoporosis drug Fosamax to become available in February.
692182
Pfizer Inc. , the world's largest drug maker, said it won US approval to sell its Lyrica pill to treat nerve pain associated with diabetes and shingles.
751178
ZURICH/FRANKFURT  - German drugmaker Merck KGaA   MRCG.DE on Thursday unveiled a surprise 16.6-billion-Swiss   franc ($13.26-billion) deal to buy Swiss biotech firm Serono,   creating a new force in European pharmaceuticals.
421575
Genentech and OSI Pharmaceuticals won federal approval yesterday to sell Tarceva, a pill to treat lung cancer. The approval by the Food and Drug Administration came well before the agency&#39;s
45750
The Food and Drug Administration told Merck &amp; Co. that it would approve the company&#39;s successor drug to the now defunct pain reliever Vioxx if it provides further safety and
208543
Vioxx was already a big success as an arthritis pain reliever, but Merck &amp; Co. thought it could be an even bigger seller. The drug seemed to have some cancer-prevention qualities
81672
The pharmaceutical giant is selling its pain relievers and other consumer products.
252163
A U.S. judge has granted a request from   Sanofi-Aventis and U.S. partner Bristol-Myers Squibb Co.   BMY.N to block the sale in the United States of a generic   form of its top selling blood-thinner Plavix, giving a boost to   shares in the French drugmaker on Friday.
525567
Drug maker Merck & Co. Inc.  urged U.S. advisers on Thursday to approve the first over-the-counter sales of a cholesterol-lowering pill, but regulators questioned if consumers would use it properly.
291258
Merck &amp; Co., the drug maker defending about 27,000 lawsuits filed by users of the painkiller Vioxx, was accused in a Canadian lawsuit of failing to warn consumers its bone drug Fosamax may damage jaw bones, a law firm said.
150005
Swiss biotech firm Serono SA, which earlier Thursday agreed to sell a majority stake in the company to German drugmaker Merck KGaA for $13.31 billion, said its oral cladribine treatment for multiple sclerosis has received "fast-track" status from the U.S. Food and Drug Administration.
132487
For those that missed it last night, Biogen Idec (BIIB:Nasdaq - news - research) and Elan Pharmaceuticals (ELN:NYSE ADR - news - research) received FDA approval for their new multiple sclerosis drug, now called Tysabri (formerly known as Antegren.
191337
GlaxoSmithKline won permission yesterday from the Food and Drug Administration to sell a tumor-growth inhibitor called Tykerb to treat breast cancer.
722689
BETHESDA, Md.  - Drug maker Merck & Co. Inc.   urged U.S. advisers on Thursday to approve the first  over-the-counter sales of a cholesterol-lowering pill, but  regulators questioned if consumers would use it properly.
263089
A Merck &amp; Co. Inc. drug received federal approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells.
429824
TRENTON, N.J. - Pharmaceutical giant Merck & Co...
418396
Swiss biotech company Addex Pharmaceuticals SA  could receive more than $700 million from Merck & Co Inc  for a licensing deal on its ADX63365 drug for schizophrenia.